BFD Management Team
Dr. Satya Prakash
PhD Prof. Biomed engineering, Experimental MEDICINE, Physiology & Experimental Surgery McGill University
Dr. Prakash is a Full Professor of Biomedical Engineering, Artificial Cells and Organs, Physiology, Experimental Medicine and Surgery in the Faculty of Medicine at the prestigious McGill University in Montreal, Quebec, Canada.
Dr. Prakash has established a long-standing and world-renowned reputation as a pioneer in the fields of microbiome and probiotics, and human health. His research has led to the discovery of novel links between microflora, metabolic pathways, and diseases. He also developed novel microbiome-based therapy platforms, which have the potential to transform modern medicine and human health.
Dr. Prakash is considered the father of enzyme mechanism-based therapeutic probiotics. He was the first to propose that bacterial by oral feeding can be used to modulate gut microbiota and metabolites and to treat complex diseases such as kidney failure. These findings were published in the prestigious journal, Nature Medicine (Prakash and Chang, Nature Medicine, 1996). Since then, he has transformed the microbiome of human health research and the probiotic industry through his range of discoveries and entrepreneurship.
In 2003 Dr. Prakash founded Micropharma, an innovative company that launched Cardioviva™, the world’s first Lactobacillus probiotic with a health claim. With global recognition and an investment of 22 Million USD from France Group Danone, Micropharma showcased a patented probiotic strain, LRC™ that has gained regulatory approval by the US FDA and Health Canada and has been consumed by millions globally since its launch. In 2019 alone, 38 million people used the LRC™ probiotics under various names to reduce blood cholesterol and improve overall health. Dr Prakash’s success with Micropharma began a new era of BSH-based probiotics, allowing for a range of other strains to be sold and consumed by millions globally for lowering cholesterol, gut health and obesity.
Dr Prakash is the leading author of more than 350 research papers/abstracts and 23 book chapters, research, and other scholarly articles. His publication list includes 72 approved/pending patents and 3 edited books. Dr Prakash is also the winner of more than 30 international awards including the “Medal for Outstanding Contribution to the Advancement of Science”, China Friendship Award Shandong, Fraser, Monat and McPherson Award, Canadian Institute of Health Research Investigator Award, FRSQ Chercheure‐Boursière, and other prestigious awards.